article thumbnail

“Shift Happens” Video Ignites Discussion on How We Need to Change or We’ll be Changed

The Practical Leader

Last week I ran a highly customized Peak Performance Leadership workshop and facilitated a strategy session in beautiful Colorado Springs. Organizational Restructuring/Building. Adapting to Market Changes. We also got to experience their first heavy snowfall — there’s a season change that came too fast!

Video 56
article thumbnail

How a Turkish Bank Became the Employer of Choice

Harvard Business Review

But, as the story of Samsung demonstrates, recruitment is very much on the minds of emerging-market companies. In the next few years, in the wake of a restructuring of Turkish monetary policy, the sector revived. In 2001, Turkey experienced a financial crisis in its banking sector. Group merged its three banks (Körfez, Osmanl?,

Banking 12
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Swedish CEO Who Runs His Company Like a CrossFit Gym

Harvard Business Review

” Whether in marketing or sales, it often feels like jobs are contingent on external circumstances, the whims of executives, strategic pivots, and shareholder demands. But if you go to the marketing department and ask them, they’re usually clueless.” “Take a football player. He will always know how he performs.

CEO 8
article thumbnail

A New Model for Innovation in Big Companies

Harvard Business Review

They pay upwards of $300K to $1 million to consultancy firms that conduct market analyses and in-depth need-finding, identify new opportunities, generate promising ideas, and, often, develop ideas into working prototypes. The client company then refines these concepts and prototypes and takes them to market. A Different Approach.

article thumbnail

If Everyone Hates the FDA Approval Process, Let’s Fix It

Harvard Business Review

As a result, the cost to bring a drug to market has been estimated to be well over $1 billion — and it may be much higher. I was privileged to be invited to a recent NEWDIGS workshop to help represent the payer community. In the current paradigm, safety concerns are often not raised until well after regulatory approval.